Company · CIK 0001725160 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Zentalis Pharmaceuticals, Inc. · ZNTL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 PForm 4 → | Aug 19, 6:11 pm EDT | WALTERS GROUP +210% Owner | 4,335,000 | $3.50 | $15,172,500 | 17,844,973 | +32.1% | late |
| Jun 16, 2026 AForm 4 → | Jun 18, 4:09 pm EDT | David Michael JohnsonDirector | 57,100 | — | — | 307,521 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 4:08 pm EDT | Jan SkvarkaDirector | 57,100 | — | — | 264,254 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 4:07 pm EDT | Luke Nathaniel WalkerDirector | 57,100 | — | — | 201,384 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 4:07 pm EDT | Enoch KariukiDirector | 57,100 | — | — | 194,465 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 4:06 pm EDT | Scott Dunseth MyersDirector | 57,100 | — | — | 395,895 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.